Clinical trial

Working Out M0 Bipolar Androgen Therapy

NCT06594926

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-08-14

PhasePHASE2

Study timeline

Study start (actual)2024-08-14Date precision: day

Registry last updated2026-04-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Testosterone EnanthateDRUG · verified · RxNorm: testosterone enanthate

Sponsors & collaborators

Australian and New Zealand Urogenital and Prostate Cancer Trials Grouplead sponsor

Bayercollaborator

The George Institutecollaborator

HMRIcollaborator

Mapped research locations

AdelaideSouth Australia, Australia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06594926 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.